Andreas Lundqvist Selected Research

Andreas Lundqvist Research Topics

Disease

58	Neoplasms (Cancer) 05/2024 - 01/2002
11	Melanoma (Melanoma, Malignant) 01/2023 - 07/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 07/2006
4	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2013 - 05/2006
3	Breast Neoplasms (Breast Cancer) 05/2024 - 03/2012
3	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2012
3	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 01/2004
2	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 01/2020
2	Multiple Myeloma 05/2023 - 01/2023
2	Hypoxia (Hypoxemia) 01/2023 - 11/2022
2	Leukemia 11/2022 - 01/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2015
2	Carcinoma (Carcinomatosis) 11/2018 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 02/2015 - 03/2008
2	Infections 05/2005 - 10/2004
1	Uveal melanoma 01/2024
1	Monosomy 01/2024
1	Experimental Melanoma 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2023 - 01/2004
10	LigandsIBA 10/2017 - 07/2006
7	Bortezomib (Velcade)FDA Link 08/2013 - 07/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 05/2005
5	CytokinesIBA 01/2023 - 07/2019
5	Interleukin-15 (Interleukin 15)IBA 01/2023 - 01/2016
4	Interleukin-2 (IL2)IBA 01/2021 - 01/2011
4	ChemokinesIBA 01/2020 - 01/2016
4	VaccinesIBA 10/2017 - 01/2004
3	Immune Checkpoint InhibitorsIBA 05/2023 - 11/2020
3	Dinoprostone (PGE2)FDA Link 01/2021 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2012
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 05/2005
3	Chemokine ReceptorsIBA 01/2018 - 11/2014
3	Peptides (Polypeptides)IBA 10/2017 - 02/2010
3	Death Domain ReceptorsIBA 10/2013 - 07/2006
3	Caspase 8 (Caspase-8)IBA 10/2013 - 06/2009
3	Proteasome InhibitorsIBA 08/2013 - 07/2006
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2020
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
2	Adenosine (Adenocard)FDA LinkGeneric 11/2022 - 01/2022
2	PerforinIBA 01/2022 - 06/2009
2	Interleukin-10 (Interleukin 10)IBA 11/2021 - 05/2005
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2020 - 05/2005
2	InterferonsIBA 07/2019 - 10/2017
2	AntibodiesIBA 07/2019 - 10/2014
2	EpitopesIBA 10/2017 - 03/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2009
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 10/2014 - 01/2013
2	HLA-DR Antigens (HLA-DR)IBA 08/2014 - 07/2013
2	Granzymes (Granzyme)IBA 02/2014 - 06/2009
1	Interleukin-6 (Interleukin 6)IBA 05/2024
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2024
1	ChromatinIBA 04/2024
1	4-1BB Ligand (4 1BB Ligand)IBA 01/2024
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2024
1	Monoclonal AntibodiesIBA 05/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Antigen Receptors (Antigen Receptor)IBA 01/2023
1	ProstaglandinsIBA 11/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022
1	Therapeutic UsesIBA 11/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	Purinergic P1 Receptor AntagonistsIBA 01/2022
1	B-Cell Maturation AntigenIBA 01/2022
1	Auranofin (Ridaura)FDA Link 01/2022
1	Interleukin-33IBA 11/2021
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	Histocompatibility Antigens Class IIBA 11/2021
1	Prostaglandin-E SynthasesIBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 10/2020
1	AntioxidantsIBA 10/2020
1	ThioredoxinsIBA 10/2020
1	pembrolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	CXCR3 ReceptorsIBA 01/2020
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2020
1	KynurenineIBA 01/2019
1	DNA VaccinesIBA 11/2018
1	Cancer VaccinesIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Poly I-CIBA 10/2017
1	Toll-Like Receptor AgonistsIBA 10/2017
1	IpilimumabIBA 03/2017
1	Zoledronic Acid (Zometa)FDA Link 01/2017
1	HLA-A Antigens (HLA-A)IBA 01/2016
1	HLA-G Antigens (HLA G)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 02/2015

Therapy/Procedure

24	Immunotherapy 05/2023 - 01/2002
23	Therapeutics 05/2023 - 01/2004
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 10/2013
4	Stem Cell Transplantation 01/2009 - 07/2005
3	Ligation 01/2024 - 06/2009
3	Cell Transplantation 06/2006 - 07/2005
2	Hematopoietic Stem Cell Transplantation 03/2008 - 07/2005
1	Precision Medicine 01/2020